U.S. flag

An official website of the United States government

NM_005592.4(MUSK):c.2368G>A (p.Val790Met) AND Congenital myasthenic syndrome 9

Germline classification:
Pathogenic (2 submissions)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000008722.5

Allele description [Variation Report for NM_005592.4(MUSK):c.2368G>A (p.Val790Met)]

NM_005592.4(MUSK):c.2368G>A (p.Val790Met)

Gene:
MUSK:muscle associated receptor tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q31.3
Genomic location:
Preferred name:
NM_005592.4(MUSK):c.2368G>A (p.Val790Met)
HGVS:
  • NC_000009.12:g.110800746G>A
  • NG_016016.2:g.136956G>A
  • NM_001166280.2:c.2110G>A
  • NM_001166281.2:c.2080G>A
  • NM_001369398.1:c.1108G>A
  • NM_005592.4:c.2368G>AMANE SELECT
  • NP_001159752.1:p.Val704Met
  • NP_001159753.1:p.Val694Met
  • NP_001356327.1:p.Val370Met
  • NP_005583.1:p.Val790Met
  • NC_000009.11:g.113563026G>A
  • NG_016016.1:g.136976G>A
  • NM_005592.3:c.2368G>A
  • O15146:p.Val790Met
Protein change:
V370M; VAL790MET
Links:
UniProtKB: O15146#VAR_023046; OMIM: 601296.0001; dbSNP: rs199476083
NCBI 1000 Genomes Browser:
rs199476083
Molecular consequence:
  • NM_001166280.2:c.2110G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001166281.2:c.2080G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369398.1:c.1108G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005592.4:c.2368G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital myasthenic syndrome 9
Synonyms:
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency
Identifiers:
MONDO: MONDO:0014587; MedGen: C4225368; Orphanet: 590; OMIM: 616325

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000028931OMIM
no assertion criteria provided
Pathogenic
(Dec 15, 2004)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV003841228Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicunknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

MUSK, a new target for mutations causing congenital myasthenic syndrome.

Chevessier F, Faraut B, Ravel-Chapuis A, Richard P, Gaudon K, Bauché S, Prioleau C, Herbst R, Goillot E, Ioos C, Azulay JP, Attarian S, Leroy JP, Fournier E, Legay C, Schaeffer L, Koenig J, Fardeau M, Eymard B, Pouget J, Hantaï D.

Hum Mol Genet. 2004 Dec 15;13(24):3229-40. Epub 2004 Oct 20.

PubMed [citation]
PMID:
15496425

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000028931.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 27-year-old French woman with congenital myasthenic syndrome-9 (CMS9; 616325) associated with AChR deficiency, Chevessier et al. (2004) identified compound heterozygosity for a 2368G-A transition in exon 14 of the MUSK gene, resulting in a val790-to-met (V790M) substitution, and a 1-bp insertion (220insC; 601296.0002) in exon3, resulting in a frameshift and premature termination at codon 92. Muscle biopsy showed dramatic pre- and postsynaptic structural abnormalities of the neuromuscular junction and severe decrease in CHRNE (100725) and MUSK expression. Genetic analysis of biopsy sections from her similarly affected brother, who died at age 1.5 years, showed that he was also compound heterozygous for both mutations. Expression experiments revealed that the frameshift mutation led to the absence of MUSK expression. The missense mutation did not affect MUSK catalytic kinase activity but diminished expression and stability of MUSK, leading to decreased agrin-dependent AChR aggregation, which is a critical step in the formation of the neuromuscular junction. In electroporated mouse muscle, overexpression of V790M mutant induced, within a week, a severe decrease in synaptic AChR and an aberrant axonal outgrowth.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV003841228.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025